Arkema S.A

PINK:ARKAF USA Specialty Chemicals
Market Cap
$6.71 Billion
Market Cap Rank
#2951 Global
#1999 in USA
Share Price
$88.66
Change (1 day)
+0.00%
52-Week Range
$88.66 - $88.66
All Time High
$140.98
About

Arkema S.A. manufactures and sells specialty materials in Europe, the United States, Canada, Mexico, China, Hong Kong, Taiwan, and internationally. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and… Read more

Arkema S.A (ARKAF) - Net Assets

Latest net assets as of September 2025: $7.42 Billion USD

Based on the latest financial reports, Arkema S.A (ARKAF) has net assets worth $7.42 Billion USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($14.30 Billion) and total liabilities ($6.88 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $7.42 Billion
% of Total Assets 51.91%
Annual Growth Rate 7.83%
5-Year Change 48.25%
10-Year Change 138.07%
Growth Volatility 15.57

Arkema S.A - Net Assets Trend (2004–2024)

This chart illustrates how Arkema S.A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Arkema S.A (2004–2024)

The table below shows the annual net assets of Arkema S.A from 2004 to 2024.

Year Net Assets Change
2024-12-31 $7.76 Billion +4.10%
2023-12-31 $7.46 Billion +1.58%
2022-12-31 $7.34 Billion +15.57%
2021-12-31 $6.35 Billion +21.30%
2020-12-31 $5.24 Billion -1.67%
2019-12-31 $5.32 Billion +22.70%
2018-12-31 $4.34 Billion +18.33%
2017-12-31 $3.67 Billion +3.01%
2016-12-31 $3.56 Billion +9.20%
2015-12-31 $3.26 Billion -8.76%
2014-12-31 $3.57 Billion +52.11%
2013-12-31 $2.35 Billion +1.64%
2012-12-31 $2.31 Billion +4.24%
2011-12-31 $2.22 Billion -1.03%
2010-12-31 $2.24 Billion +23.55%
2009-12-31 $1.81 Billion -10.16%
2008-12-31 $2.02 Billion +4.29%
2007-12-31 $1.94 Billion -0.15%
2006-12-31 $1.94 Billion +32.47%
2005-12-31 $1.46 Billion -14.79%
2004-12-31 $1.72 Billion --

Equity Component Analysis

This analysis shows how different components contribute to Arkema S.A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 163.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings $4.62 Billion 61.41%
Common Stock $761.00 Million 10.11%
Other Comprehensive Income $1.05 Billion 13.93%
Other Components $1.09 Billion 14.55%
Total Equity $7.53 Billion 100.00%

Arkema S.A Competitors by Market Cap

The table below lists competitors of Arkema S.A ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Arkema S.A's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 7,203,000,000 to 7,526,000,000, a change of 323,000,000 (4.5%).
  • Net income of 354,000,000 contributed positively to equity growth.
  • Dividend payments of 261,000,000 reduced retained earnings.
  • Share repurchases of 35,000,000 reduced equity.
  • New share issuances of 63,000,000 increased equity.
  • Other comprehensive income increased equity by 178,000,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $354.00 Million +4.7%
Dividends Paid $261.00 Million -3.47%
Share Repurchases $35.00 Million -0.47%
Share Issuances $63.00 Million +0.84%
Other Comprehensive Income $178.00 Million +2.37%
Other Changes $24.00 Million +0.32%
Total Change $- 4.48%

Book Value vs Market Value Analysis

This analysis compares Arkema S.A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.97x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 3.31x to 0.97x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2004-12-31 $26.75 $88.66 x
2005-12-31 $23.04 $88.66 x
2006-12-31 $29.62 $88.66 x
2007-12-31 $30.41 $88.66 x
2008-12-31 $31.87 $88.66 x
2009-12-31 $28.60 $88.66 x
2010-12-31 $35.02 $88.66 x
2011-12-31 $33.94 $88.66 x
2012-12-31 $34.98 $88.66 x
2013-12-31 $35.18 $88.66 x
2014-12-31 $53.08 $88.66 x
2015-12-31 $43.41 $88.66 x
2016-12-31 $46.60 $88.66 x
2017-12-31 $49.33 $88.66 x
2018-12-31 $56.17 $88.66 x
2019-12-31 $68.82 $88.66 x
2020-12-31 $67.63 $88.66 x
2021-12-31 $83.09 $88.66 x
2022-12-31 $98.09 $88.66 x
2023-12-31 $95.98 $88.66 x
2024-12-31 $91.20 $88.66 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Arkema S.A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 4.70%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 3.71%
  • • Asset Turnover: 0.63x
  • • Equity Multiplier: 2.02x
  • Recent ROE (4.70%) is above the historical average (4.34%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 -34.14% -10.93% 1.19x 2.62x $-751.20 Million
2005 -29.54% -7.76% 1.18x 3.22x $-572.90 Million
2006 2.44% 0.83% 1.25x 2.36x $-145.30 Million
2007 6.48% 2.19% 1.28x 2.32x $-67.40 Million
2008 5.01% 1.78% 1.26x 2.24x $-99.60 Million
2009 -9.60% -3.87% 1.13x 2.20x $-351.10 Million
2010 15.64% 5.88% 1.23x 2.17x $125.10 Million
2011 -0.87% -0.32% 1.11x 2.43x $-238.00 Million
2012 9.64% 3.44% 1.15x 2.43x $-8.20 Million
2013 7.27% 2.76% 1.11x 2.37x $-63.20 Million
2014 4.73% 2.81% 0.87x 1.93x $-185.90 Million
2015 8.88% 3.71% 0.86x 2.77x $-36.10 Million
2016 12.15% 5.67% 0.82x 2.63x $75.50 Million
2017 15.38% 6.92% 0.87x 2.56x $201.60 Million
2018 16.48% 8.02% 0.87x 2.36x $278.00 Million
2019 10.30% 6.21% 0.80x 2.08x $15.70 Million
2020 6.40% 4.21% 0.74x 2.06x $-186.70 Million
2021 20.77% 13.75% 0.77x 1.95x $678.70 Million
2022 13.22% 8.35% 0.85x 1.85x $235.00 Million
2023 5.80% 4.39% 0.66x 2.02x $-302.30 Million
2024 4.70% 3.71% 0.63x 2.02x $-398.60 Million

Industry Comparison

This section compares Arkema S.A's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $7,181,833,981
  • Average return on equity (ROE) among peers: 7.11%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Arkema S.A (ARKAF) $7.42 Billion -34.14% 0.93x $4.59 Billion
AirBoss of America Corp (ABSSF) $197.00 Million -16.19% 1.24x $57.06 Million
Asia Carbon Industries Inc (ACRB) $19.13 Million 17.11% 0.33x $0.98
Aimia Inc (AIMFF) $1.29 Billion -4.63% 2.83x $103.68 Million
L'Air Liquide S.A (AIQUF) $11.83 Billion 14.08% 1.26x $107.70 Billion
Akzo Nobel N.V (AKZOF) $7.58 Billion 14.03% 1.29x $9.73 Billion
Albemarle Corp (ALB) $545.00 Million 9.41% 1.09x $19.53 Billion
ALPEK S.A.B. de C.V (ALPKF) $49.59 Billion 15.64% 1.50x $214.40 Million
Altech Batteries Limited (ALTHF) $97.54 Million -5.87% 0.01x $27.89 Million
Arcadium Lithium plc (ALTM) $333.00 Million 14.14% 0.12x $6.26 Billion
Alto Ingredients Inc (ALTO) $345.21 Million 13.35% 0.40x $212.84 Million